Company

ZAI Lab Limited

ZAI Lab is a Shanghai biopharmaceutical company developing therapeutics for oncology, autoimmune and infectious diseases.

About

Founded in 2014 and based in Shanghai, China, ZAI Lab Limited discovers and develops therapeutics for oncology, autoimmune and infectious diseases, with R&D in Shanghai, manufacturing in Suzhou and offices in Beijing, Hong Kong, Taiwan and Guangzhou. It listed on the Hong Kong Stock Exchange in September 2020 with stock code 9688, after a USD 172 million NASDAQ IPO in September 2017. In December 2024 it raised CNY 300 million in venture debt from Bank of Communications.

4Funding rounds

7Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in